Published in Genetics and Environmental Business Week, August 28th, 2008
"The aim was to determine the role of genetic polymorphisms in MDR-1 with respect to interindividual variability of CsA blood concentrations in myasthenia gravis (MG) patients. MG patients (n = 129) receiving CsA were genotyped for MDR-1 1236C-- >T (exon 12), 2677G-- >T (exon 21) and 3435C-- >T (exon 26)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.